Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Despite initial pharmaceutical interest, AOD 9604 did not progress through the full clinical trial pathway required for regulatory approval, and it holds no Marketing Authorisation (MA) from the MHRA or EMA
Some GPs still adhere to this criteria and NICE Guidelines bizarrely reinforce it for patients diagnosed with CFS and ME too
The clinical development program was discontinued due to insufficient weight loss efficacy rather than safety concerns
The addition of B12 to their treatment protocol may help lessen their discomfort and improve their quality of life
Product Specifications Research Overview 5-Amino-1MQ is a small molecule, not a peptide, and getting that right is the first step in reading the literature: searches for 5 amino 1mq peptide return a compound that is chemically a quaternary quinolinium salt
Adequate levels of these neurotransmitters are important for maintaining good mood and overall mental well-being
